润都股份(002923)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002923 润都股份

已收盘 07-19 15:00:00

{"stockData":{"symbol":"002923","market":"SZ","secType":"STK","nameCN":"润都股份","latestPrice":9.12,"timestamp":1721372595000,"preClose":9.12,"halted":0,"volume":1055554,"delay":0,"floatShares":258000000,"shares":335000000,"eps":0.1658,"marketStatus":"已收盘","marketStatusCode":5,"change":0,"latestTime":"07-19 15:00:00","open":9.15,"high":9.15,"low":8.95,"amount":9586600,"amplitude":0.0219,"askPrice":9.12,"askSize":45,"bidPrice":9.11,"bidSize":82,"shortable":0,"etf":0,"ttmEps":0.1658,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721611800000},"adr":0,"adjPreClose":9.12,"symbolType":"stock","openAndCloseTimeList":[[1721352600000,1721359800000],[1721365200000,1721372400000]],"highLimit":10.03,"lowLimit":8.21,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":334893286,"pbRate":2.53,"roa":"--","roe":"2.43%","epsLYR":0.2,"committee":0.015567,"marketValue":3054000000,"floatMarketCap":2354000000,"peRate":55.00603,"changeRate":0,"turnoverRate":0.0041,"status":2},"requestUrl":"/m/hq/s/002923/tweets","defaultTab":"tweets","newsList":[{"id":"2451550358","title":"润都股份（002923）股东李希质押88.53万股，占总股本0.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451550358","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451550358?lang=zh_cn&edition=full","pubTime":"2024-07-13 03:26","pubTimestamp":1720812388,"startTime":"0","endTime":"0","summary":"证券之星消息，润都股份7月13日公开信息显示，股东李希向华西证券股份有限公司合计质押88.53万股，占总股本0.26%。质押详情见下表：截止本公告日，股东李希已累计质押股份7492.83万股，占其持股总数的74.29%。润都股份主营业务：主要从事化学原料药及医药中间体、化学药制剂的研发、生产和销售,产品应用范围涵盖消化性溃疡、高血压、手术局部麻醉、解热镇痛、感染类疾病、糖尿病等多个用药领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071300003788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002923","BK0239"],"gpt_icon":0},{"id":"2449470981","title":"润都股份最新公告：伏立康唑原料药获得CEP证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2449470981","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449470981?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:10","pubTimestamp":1720447813,"startTime":"0","endTime":"0","summary":"润都股份公告，近日收到欧洲药品质量管理局签发的关于伏立康唑原料药欧洲药典适用性证书。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800032474.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002923","BK0239"],"gpt_icon":0},{"id":"2449776825","title":"润都股份(002923.SZ)：伏立康唑原料药获得CEP证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2449776825","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449776825?lang=zh_cn&edition=full","pubTime":"2024-07-08 19:13","pubTimestamp":1720437185,"startTime":"0","endTime":"0","summary":"智通财经APP讯， 润都股份 发布公告，公司近日收到欧洲药品质量管理局签发的关于伏立康唑原料药欧洲药典适用性证书。据悉，本品是由美国辉瑞研发的一种广谱三唑类抗真菌药物；其作用机制是抑制真菌中由细胞色素P450介导的14α-甾醇去甲基化，从而抑制麦角甾醇的生物合成。体外试验表明伏立康唑具有广谱抗真菌作用。此外，伏立康唑在体外对其他致病性真菌也有杀菌作用，包括对现有抗真菌药敏感性较低的菌属。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1147178.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002923","BK0239"],"gpt_icon":0},{"id":"2448646605","title":"青蒿素概念盘中跳水，润都股份跌2.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448646605","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448646605?lang=zh_cn&edition=full","pubTime":"2024-07-04 09:56","pubTimestamp":1720058168,"startTime":"0","endTime":"0","summary":"07月04日，青蒿素概念盘中跳水，截至09点56分，青蒿素概念整体指数下跌1.05%，报1053.010点。从个股上来看，该概念的成分股中，润都股份跌2.32%，德龙汇能、海正药业、复星医药跌幅居前。从资金上来看，截止发稿，青蒿素概念主力净流入为-1631.20万，其中复星医药受到资金热捧，主力净流入817.88万；拉长时间线来看，该板块近20日主力资金净流入4197.48万。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240704095608af90791a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240704095608af90791a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600196","BK0028","BK0175","BK0060","BK0196","BK0239","BK0012","BK0183","BK0188","002923","BK0187","BK0096","02196"],"gpt_icon":0},{"id":"2448871181","title":"7月2日润都股份发生1笔大宗交易 成交金额414.21万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448871181","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448871181?lang=zh_cn&edition=full","pubTime":"2024-07-02 16:40","pubTimestamp":1719909648,"startTime":"0","endTime":"0","summary":"证券之星消息，7月2日润都股份发生大宗交易，交易数据如下：大宗交易成交价格9.35元，相对当日收盘价折价2.5%，成交44.3万股，成交金额414.21万元，买方营业部为兴业证券股份有限公司上海锦康路证券营业部，卖方营业部为第一创业证券股份有限公司广州分公司。近三个月该股共发生1笔大宗交易，合计成交4430.0手，折价成交1笔。截至2024年7月2日收盘，润都股份报收于9.59元，上涨1.48%，换手率0.62%，成交量1.59万手，成交额1522.46万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070200024083.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002923"],"gpt_icon":0},{"id":"2448968087","title":"润都股份(002923.SZ)：缬沙坦氢氯噻嗪片获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2448968087","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448968087?lang=zh_cn&edition=full","pubTime":"2024-07-01 16:07","pubTimestamp":1719821246,"startTime":"0","endTime":"0","summary":"智通财经APP讯，润都股份(002923.SZ)发布公告，公司近日收到国家药品监督管理局签发的《药品注册证书》，涉及药品：“缬沙坦氢氯噻嗪片”。据悉，缬沙坦氢氯噻嗪片由Novartis(诺华)研发，为缬沙坦和氢氯噻嗪的复方固体制剂，于1998年03月在美国上市。本品用于治疗单一药物不能充分控制血压的轻度~中度原发性高血压;不适合高血压的初始治疗。本品获得国家药监局的《药品注册证书》，标志着公司具备了在国内市场销售该药品的资格，进一步丰富了公司的产品线，有助于提升公司产品的市场竞争力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1143518.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002923","BK0239"],"gpt_icon":0},{"id":"2443975062","title":"润都股份(002923.SZ)就媒体报道澄清：与宏升药业无股权或关联关系 亦无业务往来","url":"https://stock-news.laohu8.com/highlight/detail?id=2443975062","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443975062?lang=zh_cn&edition=full","pubTime":"2024-06-16 22:37","pubTimestamp":1718548627,"startTime":"0","endTime":"0","summary":"智通财经APP讯，润都股份 发布公告，近期，有媒体刊登或转载了以“润都股份被指涉嫌生产、销售有毒有害食品”为题的报道。公司同步就该事项进行了内部核查，现说明如下：公司与宏升药业无股权或关联关系，近三年间亦无业务往来。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1135915.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002923"],"gpt_icon":0},{"id":"2442368185","title":"润都股份：2024年06月10日为非交易日，公司2024年06月07日盘后持股户数为14,265户","url":"https://stock-news.laohu8.com/highlight/detail?id=2442368185","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442368185?lang=zh_cn&edition=full","pubTime":"2024-06-12 18:02","pubTimestamp":1718186562,"startTime":"0","endTime":"0","summary":"证券之星消息，润都股份(002923)06月12日在投资者关系平台上答复投资者关心的问题。投资者：问6月10日盘后股东人数。谢谢润都股份董秘：您好！2024年06月10日为非交易日，公司2024年06月07日盘后持股户数为14,265户。感谢您的关注！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061200034857.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002923"],"gpt_icon":0},{"id":"2440474908","title":"润都股份：5月31日组织现场参观活动，海通证券、华凯医疗等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2440474908","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440474908?lang=zh_cn&edition=full","pubTime":"2024-06-04 14:26","pubTimestamp":1717482378,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年6月3日润都股份发布公告称公司于2024年5月31日组织现场参观活动，海通证券、华凯医疗、海泽基金、金字塔投资、聚亿基金、景瑞私募、和兴资本、圆梦腾飞、爱姆斯坦、珠海科技学院、太和私募、凡旭资产、北斗星、华擎实业、一鉴开投资、稻兴资本、恒基达鑫、珠海上市公司协会、和诚基金参与。该股最近90天内共有1家机构给出评级，买入评级1家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060400022574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0276","BK0012","BK0183","BK0188","BK1564","002923","159891","BK0070","600837","06837","BK1147"],"gpt_icon":0},{"id":"2438859978","title":"润都股份(002923.SZ)拟10股派2元 于5月31日除权除息","url":"https://stock-news.laohu8.com/highlight/detail?id=2438859978","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438859978?lang=zh_cn&edition=full","pubTime":"2024-05-26 15:51","pubTimestamp":1716709878,"startTime":"0","endTime":"0","summary":"智通财经APP讯，润都股份(002923.SZ)公告，公司2023年年度权益分派拟：向全体股东每10股派发现金红利2元(含税)。除权除息日为：2024年5月31日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1126170.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002923"],"gpt_icon":0},{"id":"2437749130","title":"【机构调研记录】恒生前海基金调研润都股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2437749130","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437749130?lang=zh_cn&edition=full","pubTime":"2024-05-24 08:01","pubTimestamp":1716508909,"startTime":"0","endTime":"0","summary":"；公司雷贝拉唑钠肠溶胶囊产品辅助用于胃溃疡或十二指肠溃疡患者根除幽门螺旋杆菌。恒生前海基金成立于2016年，截至目前，资产管理规模129.4亿元，排名126/203；资产管理规模129.4亿元，排名113/203；管理公募基金数41只，排名107/203；旗下公募基金经理6人，排名137/203。旗下最近一年表现最佳的公募基金产品为恒生前海港股通高股息指数，最新单位净值为0.94，近一年增长23.05%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052400011732.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002923","BK0239"],"gpt_icon":0},{"id":"2437774913","title":"【机构调研记录】东财基金调研三鑫医疗、润都股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2437774913","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437774913?lang=zh_cn&edition=full","pubTime":"2024-05-24 08:01","pubTimestamp":1716508870,"startTime":"0","endTime":"0","summary":"；公司雷贝拉唑钠肠溶胶囊产品辅助用于胃溃疡或十二指肠溃疡患者根除幽门螺旋杆菌。东财基金成立于2018年，截至目前，资产管理规模56.58亿元，排名149/203；资产管理规模56.58亿元，排名129/203；管理公募基金数89只，排名69/203；旗下公募基金经理12人，排名98/203。旗下最近一年表现最佳的公募基金产品为东财家电A，最新单位净值为0.99，近一年增长17.51%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052400011684.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300453","BK0251","002923"],"gpt_icon":0},{"id":"2435653805","title":"润都股份（002923）5月14日主力资金净卖出984.85万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435653805","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435653805?lang=zh_cn&edition=full","pubTime":"2024-05-14 15:28","pubTimestamp":1715671723,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年5月14日收盘，润都股份报收于11.17元，下跌1.85%，换手率6.79%，成交量17.51万手，成交额1.97亿元。5月14日的资金流向数据方面，主力资金净流出984.85万元，占总成交额4.99%，游资资金净流出101.55万元，占总成交额0.51%，散户资金净流入1086.4万元，占总成交额5.51%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051400016092.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002923"],"gpt_icon":0},{"id":"2435313243","title":"润都股份新提交1件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2435313243","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435313243?lang=zh_cn&edition=full","pubTime":"2024-05-13 13:10","pubTimestamp":1715577036,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，近日珠海润都制药股份有限公司新提交1件商标注册申请。商标申请详情如下：今年以来珠海润都制药股份有限公司新申请注册商标41件，截止目前公司共持有注册商标609件，另有57件商标尚在注册申请中。数据来源：企查查以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051300007223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002923","BK0239"],"gpt_icon":0},{"id":"2435395909","title":"异动快报：润都股份（002923）5月13日9点45分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2435395909","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435395909?lang=zh_cn&edition=full","pubTime":"2024-05-13 09:50","pubTimestamp":1715565029,"startTime":"0","endTime":"0","summary":"证券之星5月13日盘中消息，9点45分润都股份触及涨停板。目前价格12.35，上涨9.97%。其所属行业化学制药目前上涨。领涨股为双成药业。该股为化学原料药，医药，幽门螺杆菌概念概念热股，当日化学原料药概念上涨0.17%。5月10日的资金流向数据方面，主力资金净流出528.92万元，占总成交额13.8%，游资资金净流出518.47万元，占总成交额13.53%，散户资金净流入1047.4万元，占总成交额27.33%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051300003460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002923","BK0239"],"gpt_icon":0},{"id":"2434337563","title":"润都股份：公司未向诺华供应沙库巴曲缬沙坦钠原料药","url":"https://stock-news.laohu8.com/highlight/detail?id=2434337563","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434337563?lang=zh_cn&edition=full","pubTime":"2024-05-12 21:00","pubTimestamp":1715518832,"startTime":"0","endTime":"0","summary":"证券之星消息，润都股份05月12日在投资者关系平台上答复投资者关心的问题。公司未向诺华供应沙库巴曲缬沙坦钠原料药。主要是因为集采价格下降还是缬沙坦原料药价格下降？公司年报中未对单一产品的营收或利润进行列示。投资者：请通报一下截止5月10日盘后登记在册的股东人数润都股份董秘：公司2024年05月10日盘后持股户数为14,701户。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051200002152.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002923","BK0239"],"gpt_icon":0},{"id":"2430783360","title":"润都股份(002923.SZ)发布一季度业绩，净利润2905.58万元，下降28.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430783360","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430783360?lang=zh_cn&edition=full","pubTime":"2024-04-27 00:43","pubTimestamp":1714149829,"startTime":"0","endTime":"0","summary":"智通财经APP讯，润都股份(002923.SZ)发布2024年一季度报告，报告期内实现营业收入3.06亿元，同比下降14.82%。归属于上市公司股东的净利润2905.58万元，同比下降28.14%。归属于上市公司股东的扣除非经常性损益的净利润2557.25万元，同比下降29.80%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1112928.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002923"],"gpt_icon":0},{"id":"2430272658","title":"润都股份最新公告：一季度净利润2905.58万元 同比下降28.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430272658","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430272658?lang=zh_cn&edition=full","pubTime":"2024-04-26 21:19","pubTimestamp":1714137585,"startTime":"0","endTime":"0","summary":"润都股份公布2024年一季度报告，报告期营业收入3.06亿元，同比下降14.82%；归属于上市公司股东的净利润2905.58万元，同比下降28.14%。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600053963.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002923"],"gpt_icon":0},{"id":"2414859344","title":"润都股份(002923.SZ)：“盐酸左布比卡因注射液”通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2414859344","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2414859344?lang=zh_cn&edition=full","pubTime":"2024-02-28 19:19","pubTimestamp":1709119140,"startTime":"0","endTime":"0","summary":"润都股份(002923.SZ)发布公告，公司近日收到国家药品监督管理局签发的《药品补充申请批准通知书》，涉及产品：“盐酸左布比卡因注射液”，经审查，本品通过仿制药质量和疗效一致性评价。同时同意以下变更：1.变更药品生产工艺;2.变更直接接触药品的包装材料和容器;3.变更药品质量标准。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-28/doc-inakqwnf2305131.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-28/doc-inakqwnf2305131.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","002923"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2018-01-05","address":"广东省珠海市金湾区三灶镇机场北路6号","stockEarnings":[{"period":"1week","weight":-0.0308},{"period":"1month","weight":-0.05},{"period":"3month","weight":-0.0593},{"period":"6month","weight":-0.1395},{"period":"1year","weight":-0.2964},{"period":"ytd","weight":-0.2468}],"companyName":"珠海润都制药股份有限公司","boardCode":"AI0027","perCapita":"18092股","boardName":"医药制造业","registeredCapital":"33489万元","compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.0118},{"period":"3month","weight":-0.0271},{"period":"6month","weight":0.053},{"period":"1year","weight":-0.0591},{"period":"ytd","weight":0.0025}],"survey":"　　珠海润都制药股份有限公司主营业务为从事抗高血压沙坦类、胃肠道拉唑类、麻醉类等特色原料药和中间体的研发、生产和销售。主要产品包括：雷贝拉唑钠肠溶胶囊、厄贝沙坦胶囊、布洛芬缓释胶囊、单硝酸异山梨酯缓释胶囊、厄贝沙坦、缬沙坦等。公司是国家火炬计划重点高新技术企业、国家高新技术企业、国家企业技术中心、国家知识产权优势企业，具有较强的技术创新能力和综合竞争优势。","serverTime":1721485091330,"listedPrice":17.01,"stockholders":"14265人(较上一季度减少1.95%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"润都股份(002923)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供润都股份(002923)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"润都股份,002923,润都股份股票,润都股份股票老虎,润都股份股票老虎国际,润都股份行情,润都股份股票行情,润都股份股价,润都股份股市,润都股份股票价格,润都股份股票交易,润都股份股票购买,润都股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"润都股份(002923)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供润都股份(002923)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}